Unknown PHASE2 INTERVENTIONAL 4-arm NCT03034382

Morphine and/or Nalbuphine as Adjuvants in Ultrasound Guided Interscalene Block: for Shoulder Surgeries

Adjuvants to Ultrasonic Guided Interscalene Block In Arthroscopic Rotator Cuff Repair; Morphine and/or Nalbuphine

Sponsor: Assiut University

Interventions Bupivacaine 0.5% Lidocaine Hydrochloride 1% and epinephrine 1:400,000 Morphine Nalbuphine

Updated 8 times since 2017 Last updated: May 19, 2017 Started: Jan 31, 2016 Primary completion: May 31, 2017 Completion: Jun 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03034382, this PHASE2 trial focuses on Rotator Cuff Tear and remains ongoing. Sponsored by Assiut University, it has been updated 8 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE2
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2019 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

Jun 2018 — Jun 2019 [monthly]

Recruiting PHASE2
Jul 2017 — Jun 2018 [monthly]

Recruiting PHASE2

Status: Completed → Recruiting
Feb 2017 — Jul 2017 [monthly]

Completed PHASE2

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Asyut, Egypt